Cas:926922-37-4 tert-Butyl 4-bromo-1H-indazole-1-carboxylate manufacturer & supplier

Chemical Name:tert-Butyl 4-bromo-1H-indazole-1-carboxylate

CAS.NO:926922-37-4

Synonyms:1-Boc-4-bromo-1H-indazole;1H-Indazole-1-carboxylic acid, 4-bromo-, 1,1-dimethylethyl ester;2-Methyl-2-propanyl 4-bromo-1H-indazole-1-carboxylate;tert-Butyl 4-bromo-1H-indazole-1-carboxylate

Molecular Formula:C₁₂H₁₃BrN₂O₂

Molecular Weight:297.148

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:377.4±34.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.599

PSA:44.12000

Exact Mass:296.016022

LogP:3.88

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-Boc-4-bromo-1H-indazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-Butyl 4-bromo-1H-indazole-1-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Boc-4-bromo-1H-indazole Use and application,2-Methyl-2-propanyl 4-bromo-1H-indazole-1-carboxylate technical grade,usp/ep/jp grade.

Related News: The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. tert-Butyl 4-bromo-1H-indazole-1-carboxylate manufacturer It also said it would bar South Koreans from visiting China as tourists. tert-Butyl 4-bromo-1H-indazole-1-carboxylate supplier Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. tert-Butyl 4-bromo-1H-indazole-1-carboxylate vendor Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. tert-Butyl 4-bromo-1H-indazole-1-carboxylate factory INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.